Nicole Nelson

NAPLES, Fla., October 22, 2024 – Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology leader focused on shoulder arthroplasty, the fastest growing segment in the orthopedics market, announced that it has appointed Amy Ables, PhD, as chief commercial officer (CCO) of the organization, effective immediately. Dr. Ables joined Catalyst in…

NAPLES, Fla., - Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology leader focused on shoulder arthroplasty, the fastest growing segment in the orthopedics market, announces it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and the first surgeries have been successfully performed for the Catalyst Fracture…